Thyrocare Technologies Limited
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical an… Read more
Thyrocare Technologies Limited (THYROCARE) - Total Assets
Latest total assets as of September 2025: ₹6.80 Billion INR
Based on the latest financial reports, Thyrocare Technologies Limited (THYROCARE) holds total assets worth ₹6.80 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Thyrocare Technologies Limited - Total Assets Trend (2011–2025)
This chart illustrates how Thyrocare Technologies Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Thyrocare Technologies Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Thyrocare Technologies Limited's total assets of ₹6.80 Billion consist of 48.8% current assets and 51.3% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹176.80 Million | 2.6% |
| Accounts Receivable | ₹821.80 Million | 11.9% |
| Inventory | ₹537.90 Million | 7.8% |
| Property, Plant & Equipment | ₹1.98 Billion | 28.6% |
| Intangible Assets | ₹48.40 Million | 0.7% |
| Goodwill | ₹1.08 Billion | 15.6% |
Asset Composition Trend (2011–2025)
This chart illustrates how Thyrocare Technologies Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Thyrocare Technologies Limited's current assets represent 48.8% of total assets in 2025, a decrease from 55.4% in 2011.
- Cash Position: Cash and equivalents constituted 2.6% of total assets in 2025, down from 39.7% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 15.0% of total assets, an increase from 4.0% in 2011.
- Asset Diversification: The largest asset category is property, plant & equipment at 28.6% of total assets.
Thyrocare Technologies Limited Competitors by Total Assets
Key competitors of Thyrocare Technologies Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Thyrocare Technologies Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Thyrocare Technologies Limited generates 0.99x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Thyrocare Technologies Limited generates $ 13.21 in net profit.
Thyrocare Technologies Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.65 | 2.58 | 2.55 |
| Quick Ratio | 2.34 | 2.12 | 2.19 |
| Cash Ratio | 0.26 | 0.48 | 0.00 |
| Working Capital | ₹2.01 Billion | ₹ 1.50 Billion | ₹ 1.17 Billion |
Thyrocare Technologies Limited - Advanced Valuation Insights
This section examines the relationship between Thyrocare Technologies Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 11.97 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | 7.6% |
| Total Assets | ₹6.93 Billion |
| Market Capitalization | $258.97 Million USD |
Valuation Analysis
Below Book Valuation: The market values Thyrocare Technologies Limited's assets below their book value (0.04 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Thyrocare Technologies Limited's assets grew by 7.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Thyrocare Technologies Limited (2011–2025)
The table below shows the annual total assets of Thyrocare Technologies Limited from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹6.93 Billion | +7.59% |
| 2024-03-31 | ₹6.44 Billion | +1.76% |
| 2023-03-31 | ₹6.33 Billion | +4.12% |
| 2022-03-31 | ₹6.08 Billion | +11.33% |
| 2021-03-31 | ₹5.46 Billion | +16.29% |
| 2020-03-31 | ₹4.69 Billion | -1.14% |
| 2019-03-31 | ₹4.75 Billion | -0.89% |
| 2018-03-31 | ₹4.79 Billion | +9.91% |
| 2017-03-31 | ₹4.36 Billion | +6.38% |
| 2016-03-31 | ₹4.10 Billion | +24.31% |
| 2015-03-31 | ₹3.30 Billion | +34.12% |
| 2014-03-31 | ₹2.46 Billion | +25.03% |
| 2013-03-31 | ₹1.97 Billion | +43.38% |
| 2012-03-31 | ₹1.37 Billion | +35.80% |
| 2011-03-31 | ₹1.01 Billion | -- |